Current Position: Home >Dashboard / Analytics >Waters... noitazilaicremmoC dna tnempole Full Article
Waters... noitazilaicremmoC dna tnempole
Author: People & Interviews Source: Policy & Regulation Views: [LargeMediumSmall] Published on: 2025-06-10 04:13:24 Comments:
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists